247089-76-5 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(3-Bromophenyl)(4-fluorophenyl)Methanol is used as a key intermediate in the synthesis of various pharmaceutical compounds for the treatment of different diseases and conditions. Its unique chemical and pharmacological properties make it a promising candidate for the development of new drugs with improved efficacy and safety profiles.
Used in Medicinal Chemistry:
(3-Bromophenyl)(4-fluorophenyl)Methanol is used as a building block in the design and synthesis of novel bioactive molecules. Its presence in the molecular structure can modulate the physicochemical and biological properties of the resulting compounds, leading to the discovery of new therapeutic agents with potential applications in various medical fields.
Used in Chemical Synthesis:
(3-Bromophenyl)(4-fluorophenyl)Methanol can be used as a starting material or a reactant in various chemical reactions, enabling the synthesis of a wide range of organic compounds with diverse applications in different industries, such as materials science, agrochemicals, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 247089-76-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,7,0,8 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 247089-76:
(8*2)+(7*4)+(6*7)+(5*0)+(4*8)+(3*9)+(2*7)+(1*6)=165
165 % 10 = 5
So 247089-76-5 is a valid CAS Registry Number.
247089-76-5Relevant academic research and scientific papers
Substrate-Based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase
Baguley, Tyler D.,Xu, Hai-Chao,Chatterjee, Manavi,Nairn, Angus C.,Lombroso, Paul J.,Ellman, Jonathan A.
, p. 7636 - 7650 (2013/11/06)
High levels of striatal-enriched protein tyrosine phosphatase (STEP) activity are observed in a number of neuropsychiatric disorders such as Alzheimer's disease. Overexpression of STEP results in the dephosphorylation and inactivation of many key neuronal
CoMFA study of novel phenyl ring-substituted 3α- (diphenylmethoxy)tropane analogues at the dopamine transporter
Newman, Amy Hauck,Izenwasser, Sari,Robarge, Michael J.,Kline, Richard H.
, p. 3502 - 3509 (2007/10/03)
A series of phenyl ring-substituted analogues of 3α- (diphenylmethoxy)tropane (benztropine) has been prepared as novel probes for the dopamine transporter. Cross-validated comparative molecular field analysis (CoMFA) models of the binding domain on the do
